[NBIX] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
04-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 4.77%
YoY- 5.96%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 302,400 237,100 244,100 222,094 183,580 138,403 131,492 74.31%
PBT 83,200 38,900 38,600 58,407 52,091 -102,594 18,808 169.72%
Tax 3,600 1,500 4,600 4,618 753 -479 730 190.00%
NP 79,600 37,400 34,000 53,789 51,338 -102,115 18,078 168.88%
Tax Rate -4.33% -3.86% -11.92% -7.91% -1.45% - -3.88% -
Total Cost 222,800 199,700 210,100 168,305 132,242 240,518 113,414 56.91%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 26.32 15.77 13.93 24.22 27.96 -73.78 13.75 54.22%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS 0.86 0.40 0.37 0.59 0.56 -1.12 0.20 164.66%
EPS Diluted 0.81 0.39 0.35 0.56 0.54 -1.12 0.19 163.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.